# Chronic Respiratory Disease (Mycoplasma synoviae) in Poultry
Overview
Chronic respiratory disease caused by Mycoplasma synoviae (MS) is a significant infectious condition affecting domestic poultry, including chickens, turkeys, ducks, and geese. This bacterial pathogen belongs to the class Mollicutes and is characterized by its lack of a cell wall, making it particularly challenging to treat and eradicate from flocks.
Mycoplasma synoviae primarily targets the respiratory system and joints, causing a range of symptoms from mild respiratory signs to severe lameness and decreased productivity. The disease is economically important in commercial poultry operations due to its impact on egg production, growth rates, and overall flock health.
Unlike many other poultry diseases, MS infection often presents as a chronic condition that can persist in flocks for extended periods. The pathogen can remain dormant in infected birds and become active during periods of stress, making management particularly challenging for poultry keepers.
Causes
Mycoplasma synoviae is the sole causative agent of this chronic respiratory disease. This bacterium is unique among pathogens due to several distinctive characteristics:
The organism lacks a rigid cell wall, which makes it highly pleomorphic (variable in shape) and resistant to many common antibiotics that target cell wall synthesis. MS can survive in various environmental conditions and has the ability to adhere strongly to the respiratory epithelium and synovial membranes of joints.
Transmission occurs through multiple routes, making control efforts complex. Horizontal transmission happens through direct contact between infected and susceptible birds, aerosol droplets from respiratory secretions, and contaminated equipment, feed, or water sources. Vertical transmission from infected breeding stock to offspring can occur through the egg, allowing the pathogen to establish itself in new generations.
Environmental factors play a crucial role in disease development. Poor ventilation, overcrowding, temperature fluctuations, and high humidity create conditions that favor bacterial multiplication and transmission. Stress factors such as transportation, vaccination, dietary changes, or concurrent infections can trigger clinical disease in subclinically infected flocks.
Symptoms & Signs
Early Symptoms
In the initial stages of infection, birds may exhibit subtle respiratory signs that are often overlooked or attributed to minor environmental stressors. Mild coughing, particularly noticeable during quiet periods, may be the first indication of infection. Slight nasal discharge, initially clear but potentially becoming more viscous over time, can develop.
Birds may show decreased activity levels and reduced interest in feed, though these changes are often minimal in early stages. Some birds may exhibit slight swelling around the eyes or sinuses, and there may be a barely perceptible decrease in egg production in laying flocks.
Advanced Symptoms
As the infection progresses, respiratory signs become more pronounced and additional symptoms develop. Persistent coughing becomes more frequent and noticeable, often accompanied by difficulty breathing or open-mouth breathing in severely affected birds.
Joint involvement becomes apparent, with birds showing lameness that may affect one or multiple legs. Swollen hocks, feet, or wing joints are characteristic signs of MS infection. Birds may reluctantly move or show obvious discomfort when walking.
Egg production drops significantly in laying flocks, and egg quality may deteriorate with thin shells or abnormal shapes. Growth rates in young birds slow considerably, and feed conversion efficiency decreases markedly.
Respiratory distress becomes more evident, with birds showing increased respiratory rate and effort. Nasal discharge may become purulent, and sinusitis can develop, causing facial swelling and distortion.
Emergency Signs
Severe cases may progress to life-threatening complications requiring immediate veterinary intervention. Birds showing severe respiratory distress with gasping, inability to breathe normally, or cyanosis (blue discoloration) of combs and wattles need emergency care.
Complete inability to stand or move due to severe joint involvement indicates advanced disease. Birds that are completely off feed and water for extended periods are at risk of dehydration and metabolic complications.
Secondary bacterial infections can develop, leading to septicemia with signs including severe depression, high fever, and potential sudden death. Any bird showing signs of systemic illness combined with respiratory and joint symptoms requires immediate professional evaluation.
Diagnosis
Accurate diagnosis of Mycoplasma synoviae infection requires a combination of clinical observation, laboratory testing, and sometimes post-mortem examination. The similarity of symptoms to other respiratory diseases makes definitive diagnosis challenging without proper testing.
Clinical diagnosis begins with careful observation of flock behavior and individual bird symptoms. Veterinarians will assess the pattern of disease spread, age of affected birds, and specific symptom combinations that suggest MS infection.
Laboratory diagnosis involves several specialized tests. Serological testing using enzyme-linked immunosorbent assay (ELISA) or serum plate agglutination tests can detect antibodies against MS, indicating exposure to the pathogen. However, antibody presence doesn't always correlate with active infection.
Polymerase chain reaction (PCR) testing provides rapid and specific identification of MS genetic material from respiratory swabs, joint fluid, or tissue samples. This method is highly sensitive and can detect the pathogen even in early stages of infection.
Bacterial culture and isolation, while time-consuming and technically challenging due to the fastidious nature of mycoplasmas, remains the gold standard for definitive diagnosis. Specialized media and laboratory conditions are required for successful isolation.
Post-mortem examination of severely affected or deceased birds can reveal characteristic lesions including airsacculitis, synovitis, and sometimes pericarditis or perihepatitis.
Treatment Options
Veterinary Treatment
Treatment of Mycoplasma synoviae infection requires professional veterinary guidance due to the complex nature of the pathogen and its antibiotic resistance patterns. Several classes of antibiotics have shown efficacy against MS, but treatment protocols must be carefully designed.
Macrolide antibiotics, including tylosin, tilmicosin, and erythromycin, are commonly used first-line treatments. These antibiotics can penetrate respiratory tissues effectively and have good activity against mycoplasmas. Treatment duration typically ranges from 5-10 days, depending on severity and response.
Tetracycline-class antibiotics, such as oxytetracycline, doxycycline, and chlortetracycline, provide another treatment option. These broad-spectrum antibiotics can be administered through water, feed, or injection, offering flexibility in treatment delivery.
Fluoroquinolone antibiotics like enrofloxacin may be reserved for severe cases or when other treatments have failed. These potent antibiotics require careful use to prevent resistance development.
Supportive care plays a crucial role in treatment success. Anti-inflammatory medications may help reduce joint swelling and pain, while nutritional support ensures birds maintain adequate intake during illness.
Home Care
While professional veterinary treatment is essential, supportive home care measures can significantly improve treatment outcomes and bird comfort. Environmental management forms the foundation of supportive care.
Improving ventilation while avoiding drafts helps reduce respiratory stress and limits pathogen concentration in the air. Maintaining optimal temperature ranges prevents additional stress on infected birds.
Providing easily accessible feed and water encourages continued intake in birds with reduced mobility due to joint involvement. Elevated feeders and waterers may help birds with lameness.
Isolating severely affected birds prevents disease spread and allows for individual monitoring and care. However, complete isolation may cause stress, so visual contact with the flock should be maintained when possible.
Regular monitoring of flock behavior, feed and water consumption, and egg production helps track treatment response and identify birds requiring additional intervention.
Prevention
Preventing Mycoplasma synoviae infection requires a comprehensive approach addressing biosecurity, flock management, and environmental factors. Prevention is generally more cost-effective and successful than treatment of established infections.
Biosecurity measures form the cornerstone of prevention. Limiting access to poultry areas, requiring clean clothing and footwear for visitors, and proper disinfection of equipment and vehicles help prevent pathogen introduction.
Sourcing birds from MS-free breeding stock significantly reduces infection risk. Reputable suppliers should provide health certificates and testing records documenting freedom from mycoplasma infections.
Quarantine protocols for new birds allow for observation and testing before introduction to the main flock. A minimum 30-day quarantine period is recommended, with testing performed during this time.
Environmental management includes maintaining proper ventilation, controlling humidity levels, and preventing overcrowding. Regular cleaning and disinfection of housing areas reduces pathogen load in the environment.
Stress reduction through consistent feeding schedules, minimal handling, and gradual environmental changes helps maintain bird immunity and reduces susceptibility to infection.
Vaccination programs may be available in some regions, though vaccines for MS are less commonly used than for other poultry diseases. Consultation with a poultry veterinarian can determine if vaccination is appropriate for specific situations.
Prognosis & Recovery
The prognosis for birds with Mycoplasma synoviae infection varies significantly depending on several factors, including the severity of infection, age of affected birds, presence of concurrent diseases, and promptness of treatment initiation.
Mild cases detected early and treated appropriately often show good recovery, though complete elimination of the pathogen from individual birds may not always occur. Birds may become chronic carriers, remaining clinically normal but capable of shedding the organism during stress periods.
Severe cases involving significant joint damage may show incomplete recovery, with some birds maintaining permanent lameness or reduced mobility. Egg production in laying flocks typically improves with treatment but may not return to pre-infection levels.
Young birds generally show better recovery potential than older birds, though growth rates may remain permanently affected if infection occurred during critical development periods.
Flock-level prognosis depends on management practices, environmental conditions, and the extent of infection spread before detection and treatment. Well-managed flocks with early intervention typically show better outcomes.
When to See a Vet
Immediate veterinary consultation is essential when multiple birds show respiratory signs, lameness, or decreased production simultaneously. Early professional intervention significantly improves treatment outcomes and reduces economic losses.
Any bird showing severe respiratory distress, complete inability to stand, or signs of systemic illness requires emergency veterinary care. Delaying treatment in severe cases can result in bird death or permanent disability.
Decreased egg production, poor growth rates, or increased mortality rates in the flock warrant professional evaluation even if individual bird symptoms seem mild.
Before implementing any antibiotic treatment, veterinary consultation ensures appropriate drug selection, dosing, and duration while considering food safety withdrawal periods.
Regular veterinary health monitoring helps detect infections early and provides ongoing guidance for flock management and disease prevention strategies.